Patient preferences for the chemoprevention of colorectal cancer. - Wikidata - awgldk - TriplyDB

Patient preferences for the chemoprevention of colorectal cancer.

Patient preferences for the chemoprevention of colorectal cancer.

http://www.wikidata.org/entity/Q37080424

about

Preferences for the "screen and treat" strategy of Helicobacter pylori to prevent gastric cancer in healthy Korean populations.

P2860

Q45174723-64E23078-054C-4FB2-86A0-2564E481617B

P2860

Patient preferences for the chemoprevention of colorectal cancer.

http://www.wikidata.org/entity/Q37080424

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Patient preferences for the chemoprevention of colorectal cancer.

@en

Patient preferences for the chemoprevention of colorectal cancer.

@nl

type

label

Patient preferences for the chemoprevention of colorectal cancer.

@en

Patient preferences for the chemoprevention of colorectal cancer.

@nl

prefLabel

Patient preferences for the chemoprevention of colorectal cancer.

@en

Patient preferences for the chemoprevention of colorectal cancer.

@nl

P1433

Q37080424-22693705-AD87-4A61-BCA0-34B1C5D0DFB6

P1476

Q37080424-7735BC22-44D9-42E1-9355-216A4136BBC3

P2093

Q37080424-3A068903-2CE9-42EA-BAE6-CE0B26E7B0C9

Q37080424-5D6FB87A-0C93-429D-85E7-AC5ACF498FAA

Q37080424-A80A0091-CEBA-4450-861F-2504E552F7E8

Q37080424-B71DD7D5-10AB-4DD2-9DA7-22CB36DF1479

Q37080424-C8FC9D63-E151-4CC4-B43E-562D49DC93A2

Q37080424-E825999B-DD70-4A09-852F-462A81911F9C

Q37080424-F2DBE461-25CF-448F-AE1F-F83D27B6C60F

P2860

Q37080424-055DE8FB-F6DB-40F0-B82C-D21010D5225E

Q37080424-0C077230-2E8D-4E45-A22E-39E070441423

Q37080424-227A1E03-1583-444F-BD34-433A22E4BA63

Q37080424-328CB23A-4DA0-4FB8-BD23-FBD30E278D77

Q37080424-3B9D7E3B-ADA8-4C04-A4A9-9DD54094F172

Q37080424-7B156B3C-5C96-46FF-8F95-ABEB58DF5465

Q37080424-7B6ACCBE-E026-4DDF-B414-3276F2F356CD

Q37080424-7C622E7C-5D64-4AC5-AB72-D47B8D1C9930

Q37080424-8A579A28-32AC-4DB6-8C0B-A667C74F471F

Q37080424-8E056277-D554-4374-9127-3C2B7066D989

P2888

Q37080424-A83198B7-9623-4AAF-A945-E9C3C38AED95

P304

Q37080424-825AE54C-E304-41D3-BD60-93E568F56C37

P31

Q37080424-3B92FBF7-396F-41DA-B510-FE69C2379D0C

P356

Q37080424-FD98CB91-7F6A-43E5-83D8-81DD0CBEF879

P433

Q37080424-6FC5CA4C-FE03-4D7B-9C6B-5FF61725DBD1

P478

Q37080424-2247FB79-7C2D-4888-A458-BF60CEE6BEB0

P577

Q37080424-38103814-B48E-4F60-AD76-A8E46BB0B11B

P698

Q37080424-AB21E206-02CE-4515-8CF1-8D3639F98871

P921

Q37080424-19D663BD-EB2D-403F-ABBF-D2F258E2CA29

P932

Q37080424-1D114016-A2A5-444E-9172-4A27A6FD24E6

P356

S10620-008-0609-Z

P1433

Digestive Diseases and Sciences

P1476

Patient preferences for the chemoprevention of colorectal cancer.

@en

P2093

Chin Hur

http://www.w3.org/2001/XMLSchema#string

Chung Yin Kong

http://www.w3.org/2001/XMLSchema#string

Darcy E Broughton

http://www.w3.org/2001/XMLSchema#string

Elissa M Ozanne

http://www.w3.org/2001/XMLSchema#string

Ethan B Richards

http://www.w3.org/2001/XMLSchema#string

G Scott Gazelle

http://www.w3.org/2001/XMLSchema#string

Thanh Truong

http://www.w3.org/2001/XMLSchema#string

P2860

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

The cost-effectiveness of aspirin versus cyclooxygenase-2-selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis

Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

P2888

s10620-008-0609-z

P304

2207-2214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-008-0609-Z

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2008-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19057995

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3737565

http://www.w3.org/2001/XMLSchema#string